Showing results (181-190 of 261) with videos related to
Sort By:
Pageof 27
Antibiotics (Basel, Switzerland)|August 23, 2020
The Bristol Sponge Microbiome Collection: A Unique Repository of Deep-Sea Microorganisms and Associated Natural ProductsSam E Williams, Henry L Stennett, Catherine R Back, et al.The Journal of Sexual Medicine|November 13, 2018
Ixekizumab Improved Patient-Reported Genital Psoriasis Symptoms and Impact of Symptoms on Sexual Activity vs Placebo in a Randomized, Double-Blind StudyGil Yosipovitch, Peter Foley, Caitriona Ryan, et al.Journal of Drugs in Dermatology : JDD|February 6, 2025
Guselkumab Efficacy by Psoriasis Disease Severity and Treatment History: VOYAGE 1 and 2 Post Hoc AnalysesKenneth B Gordon, Joseph F Merola, Peter Foley, et al.Blood|November 18, 2020
Ciraparantag, an anticoagulant reversal drug: mechanism of action, pharmacokinetics, and reversal of anticoagulantsJack Ansell, Bryan E Laulicht, Sasha H Bakhru, et al.Scientific Reports|October 3, 2018
The de novo design of a biocompatible and functional integral membrane protein using minimal sequence complexityChristophe J Lalaurie, Virginie Dufour, Anna Meletiou, et al.Scientific Reports|September 17, 2020
Small-residue packing motifs modulate the structure and function of a minimal de novo membrane proteinPaul Curnow, Benjamin J Hardy, Virginie Dufour, et al.International Journal of Rheumatic Diseases|May 23, 2019
Initial assessment of the early arthritis for psoriatic patients diagnostic questionnaire in dermatology clinics in Australia, Korea and ChinaSeong-Jin Jo, Peter Foley, Stephen Philip Oakley, et al.The Australasian Journal of Dermatology|April 2, 2015
Treatment of face and scalp solar (actinic) keratosis with daylight-mediated photodynamic therapy is possible throughout the year in Australia: Evidence from a clinical and meteorological studyLynda Spelman, Diana Rubel, Dedee F Murrell, et al.International Journal of Dermatology|September 11, 2004
A prospective study of the use of cryosurgery for the treatment of actinic keratosesKeng-Ee Thai, Peter Fergin, Michael Freeman, et al.The Journal of Investigative Dermatology|June 18, 2019
Guselkumab Efficacy after Withdrawal Is Associated with Suppression of Serum IL-23-Regulated IL-17 and IL-22 in Psoriasis: VOYAGE 2 StudyKenneth B Gordon, April W Armstrong, Peter Foley, et al.Pageof 27